Predictions
Oramed Pharmaceuticals
Start price
Target price
Perf. (%)
€23.30
04.11.21
04.11.21
€10.00
04.11.23
04.11.23
-42.83%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
flatexDEGIRO AG
Start price
Target price
Perf. (%)
€20.40
03.11.21
03.11.21
-
03.11.22
03.11.22
-58.32%
04.11.22
04.11.22
Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Fair valuation
Valuable balance sheet
Yahoo Japan Corp
Start price
Target price
Perf. (%)
€5.85
02.11.21
02.11.21
-
02.11.22
02.11.22
-15.90%
07.01.22
07.01.22
Probably not worthwhile Investment
Yahoo Japan Corp
Start price
Target price
Perf. (%)
€5.85
02.11.21
02.11.21
-
02.11.22
02.11.22
-15.90%
07.01.22
07.01.22
Probably not worthwhile Investment
Yahoo Japan Corp
Start price
Target price
Perf. (%)
€5.85
02.11.21
02.11.21
-
02.11.22
02.11.22
-15.90%
07.01.22
07.01.22
Probably not worthwhile Investment
Yahoo Japan Corp
Start price
Target price
Perf. (%)
€5.85
02.11.21
02.11.21
-
02.11.22
02.11.22
-15.90%
07.01.22
07.01.22
Probably not worthwhile Investment
Yahoo Japan Corp
Start price
Target price
Perf. (%)
€5.85
02.11.21
02.11.21
-
02.11.22
02.11.22
-15.90%
07.01.22
07.01.22
Probably not worthwhile Investment
Heidelberger Druckmaschinen AG
Start price
Target price
Perf. (%)
€2.40
01.11.21
01.11.21
€4.00
01.11.22
01.11.22
-41.25%
02.11.22
02.11.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Makemytrip Ltd.
Start price
Target price
Perf. (%)
€28.40
01.11.21
01.11.21
€33.00
01.11.22
01.11.22
1.41%
02.11.22
02.11.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Kandi Technologies Corp.
Start price
Target price
Perf. (%)
€3.86
01.11.21
01.11.21
€2.00
01.11.22
01.11.22
-31.94%
21.07.22
21.07.22
EBIT growth >5% per year expected
Innovative
Future proof or reliable business model
Sustainability is little important
Cadiz Inc.
Start price
Target price
Perf. (%)
€5.35
01.11.21
01.11.21
-
01.11.22
01.11.22
-67.48%
16.03.22
16.03.22
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.40
01.11.21
01.11.21
€15.00
01.11.22
01.11.22
79.03%
02.11.22
02.11.22
Could be worthwhile Investment >10% per year
Baozun Inc ADR
Start price
Target price
Perf. (%)
€14.90
01.11.21
01.11.21
€10.00
01.11.22
01.11.22
4.03%
11.11.21
11.11.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Overstock.com
Start price
Target price
Perf. (%)
€81.92
31.10.21
31.10.21
€90.00
31.10.22
31.10.22
-47.83%
15.01.22
15.01.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Valneva SE
Start price
Target price
Perf. (%)
€19.59
31.10.21
31.10.21
€30.00
31.10.22
31.10.22
8.63%
13.11.21
13.11.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Mag Silver Corp.
Start price
Target price
Perf. (%)
€17.26
30.10.21
30.10.21
-
18.01.25
18.01.25
-25.35%
17.10.22
17.10.22
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Krystal Biotech
Start price
Target price
Perf. (%)
€42.60
30.10.21
30.10.21
€37.00
30.11.22
30.11.22
54.93%
01.12.21
01.12.21
Could be very worthwhile Investment >20% year
Bilfinger SE
Start price
Target price
Perf. (%)
€30.60
28.10.21
28.10.21
€39.00
28.10.22
28.10.22
-9.54%
21.05.22
21.05.22
Could be worthwhile Investment >10% per year
Very high dividend yield expected
McPhy Energy S.A.
Start price
Target price
Perf. (%)
€23.90
27.10.21
27.10.21
€19.00
27.10.22
27.10.22
-5.02%
03.11.21
03.11.21
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.86
27.10.21
27.10.21
€40.00
31.12.23
31.12.23
-59.32%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year